Hippo-mediated control of growth and regeneration in the inner ear sensory organs
Project Number5R01DC020268-02
Former Number1R01DC020268-01
Contact PI/Project LeaderGNEDEVA, KSENIA
Awardee OrganizationUNIVERSITY OF SOUTHERN CALIFORNIA
Description
Abstract Text
Project Summary
The main way in which non-mammalian vertebrates, such as fish, restore sensory hair cells is through
proliferation and differentiation of the residual population of supporting cells. In contrast, supporting cells lose
the capacity to proliferate postnatally in mammals, and the molecular machinery preventing cell cycle reentry
remains poorly understood.
Our work has established that Hippo signaling serves as a major repressive mechanism that blocks
supporting cell proliferation and plasticity in the mammalian inner ear. In three Aims, we will identify the molecular
mechanism by which Hippo inhibition promotes mitotic sensory receptor regeneration in the adult utricle explants
(Aim 1); assess whether reversible pharmacologic inactivation of Hippo signaling stimulates bona fide vestibular
hair cell regeneration to support functional recovery in vivo (Aim 2); and assess the pathway’s interaction with
the cell cycle inhibitor p27Kip1, specific to the organ of Corti, in the adult inner ear in vivo (Aim 3). The long-term
goal of this proposal is to identify therapeutic strategies for hearing and balance restoration through controlled
manipulation of the Hippo pathway.
Due to its relatively recent discovery, study of the Hippo pathway in the inner ear is innovative in itself.
Furthermore, our group has pioneered this field and developed several specialized research tools to aid the
study of the pathway in the inner ear. Most notably, we identified the first small-molecule inhibitor of Lats kinases
– the core enzymes in Hippo signaling – that we show to potently induce supporting cell proliferation and the
initial stages of hair cell regeneration in vitro and in vivo. We also optimized posterior semicircular canal approach
for LKI delivery into the inner ear and utilize several cutting-edge genetic and epigenetic techniques (e.g
multiome sequencing, CUT&RUN).
The proposed basic research is significant because understanding the molecular machinery blocking cell
cycle reentry in the inner ear may determine new therapeutic targets for induction of hair cell regeneration.
Remarkably, we demonstrate that brief pharmacologic inhibition of Lats kinases induces supporting cell
proliferation in the adult utricle, allowing progeny to re-exit the cell cycle and spontaneously upregulate sensory
receptor genes upon drug withdrawal. Collectively our data show that temporal inactivation of Hippo signaling is
sufficient to promote the initial stages of hair cell regeneration through supporting cell division – a process thought
to be permanently suppressed in the adult mammalian inner ear.
Public Health Relevance Statement
Project Narrative
The progressive loss of hair cells, the sensory receptors within the cochlea and vestibular system, results
in irreversible deterioration of the auditory and vestibular functions. Our work has established that Hippo signaling
serves as a major repressive mechanism preventing supporting cell-mediated hair cell regeneration in the
mammalian inner ear. The pathway, therefore, represents a new therapeutic target for induction of hair cell
regeneration, and the proposed work is directly relevant to the NIH’s mission to uncover new knowledge that will
lead to better health for everyone.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AblationAddressAdultAuditoryAuditory Brainstem ResponsesBasic ScienceBindingCell CycleCell Cycle ProgressionCell MaturationCell ProliferationCell divisionCellsChromatinCleavage Under Targets and Release Using NucleaseCochleaCyclin-Dependent Kinase InhibitorDataDeteriorationDiphtheria ToxinDyesEarEmbryoEnzymesEpigenetic ProcessEquilibriumEvoked PotentialsFishesGene ActivationGene ExpressionGenesGeneticGenetic TranscriptionGoalsGrowthHairHair CellsHealthHearingImmunohistochemistryIn VitroInjectionsInjuryKnowledgeLabelLabyrinthLinkMammalsMeasurementMeasuresMediatingMethodsMissionMitoticMolecularMolecular AnalysisMonitorMusNatural regenerationNeonatalOrganOrgan of CortiPathway interactionsPharmaceutical PreparationsPhenotypePhosphotransferasesPopulationProcessProliferatingRNAReceptor GeneRecoveryRecovery of FunctionRegimenRepressionResearchResidual stateResistanceScanning Electron MicroscopySensorySensory HairSensory ReceptorsSignal TransductionStructure of posterior semicircular canalSupporting CellTechniquesTestingTherapeuticTimeTranscription CoactivatorUnited States National Institutes of HealthUtricle structureVertebratesVestibular Hair CellsVestibular functionWorkXCL1 genecyclin-dependent kinase inhibitor 1Bdrug withdrawalexperimental studyhair cell regenerationin vitro regenerationin vivoin vivo regenerationinhibitorinnovationmultiple omicsnew therapeutic targetpharmacologicpostmitoticpostnatalpreventprogenitorrestorationsmall molecule inhibitorstem cellssynergismtooluptakevestibular system
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
072933393
UEI
G88KLJR3KYT5
Project Start Date
01-February-2023
Project End Date
31-January-2028
Budget Start Date
01-February-2024
Budget End Date
31-January-2025
Project Funding Information for 2024
Total Funding
$461,786
Direct Costs
$279,870
Indirect Costs
$181,916
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Deafness and Other Communication Disorders
$461,786
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DC020268-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DC020268-02
Patents
No Patents information available for 5R01DC020268-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DC020268-02
Clinical Studies
No Clinical Studies information available for 5R01DC020268-02
News and More
Related News Releases
No news release information available for 5R01DC020268-02
History
No Historical information available for 5R01DC020268-02
Similar Projects
No Similar Projects information available for 5R01DC020268-02